MAPT and Cognitive impairment: Similarly, in a separate cohort, women had higher tau and p-tau concentrations in early stages of mild cognitive impairment (MCI) and subjective cognitive decline, while among non APOE e4 carriers, women had higher concentrations at the later stages of AD, dementia, and MCI (BabapourMofrad et al., 2020).